• HOME
  • NEWS
  • Info
  • [Case Study] Sumitomo Pharma:Introduction of "exaBase FAQ," an AI chatbot, reduces approximately 90% of routine work inquiries and improves productivity of MRs
NEWS
2023.03.27Info

[Case Study] Sumitomo Pharma:Introduction of “exaBase FAQ,” an AI chatbot, reduces approximately 90% of routine work inquiries and improves productivity of MRs

Sumitomo Pharma introduced exaBase FAQ, an AI chatbot provided by ExaWizards, to improve the productivity of MRs (Medical Representatives) and other employees.
The system has achieved a significant improvement in operational efficiency and productivity.
Specifically, by introducing exaBase FAQ’s trained AI with an easy-to-use UI, approximately 90% of inquiries were reduced. In addition, by collecting and visualizing feedback from users and recommending improvements, the PDCA process for promoting usage has been made more efficient.

▼For more information, please visit(Only in Japanese)
https://exawizards.com/works/23348